SCHOTT PHARMA AG & CO. KGAA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.54 EUR | -5.56% |
|
-6.18% | -15.06% |
| 05-28 | SCHOTT PHARMA : Berenberg reiterates its Neutral rating | ZD |
| 05-21 | Deutsche Bank Research lowers target for Schott Pharma - 'Buy' | DP |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.
Calendar
26/06/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
28.54
EUR
Average target price
35.65
EUR
Spread / Average Target
+24.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.06% | 4.95B | |
| -8.49% | 177B | |
| -1.08% | 108B | |
| -7.69% | 65.55B | |
| +2.81% | 50.66B | |
| +6.66% | 42.58B | |
| +5.76% | 40.74B | |
| +18.48% | 31.07B | |
| +12.72% | 25.45B | |
| -5.39% | 23.93B |
- Stock Market
- Equities
- 1SXP Stock
- News SCHOTT Pharma AG & Co. KGaA
- Schott Pharma Plans New Syringe Manufacturing Facility in US
